PID11 PEGYLATED (40KDA) INTERFERON ALFA-2A (PEGASYS) SIGNIFICANTLY IMPROVES TOLERABILITY, QUALITY OF LIFE, AND WORK PRODUCTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-169.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71326-2/fulltext
Title :
PID11 PEGYLATED (40KDA) INTERFERON ALFA-2A (PEGASYS) SIGNIFICANTLY IMPROVES TOLERABILITY, QUALITY OF LIFE, AND WORK PRODUCTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71326-2&doi=10.1046/j.1524-4733.2001.40202-169.x
First page :
Section Title :
Open access? :
No
Section Order :
218